Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Locus control region for transgenic expression available for licensing

Nov. 29, 1996

No Comments

Discovery related to pharmacological screening and gene mapping available for licensing

Nov. 29, 1996

No Comments

Univ. of Washington offers cell line for screening compounds

Nov. 29, 1996

No Comments

Univ. of Washington offers human topo I-producing system for licensing

Nov. 29, 1996

No Comments

Intracardiac illuminator offered for licensing

Nov. 28, 1996

No Comments

Novel vaccine delivery system available for licensing

Nov. 28, 1996

No Comments

Licenses available for lung function monitor

Nov. 28, 1996

No Comments

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Nov. 28, 1996

No Comments

Potential drug screening invention available for licensing

Nov. 27, 1996

No Comments

Tularik receives patent coverage relating to drug discovery efforts

Nov. 26, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies, BioWorld Science
RSS

Locus control region for transgenic expression available for licensing

Discovery related to pharmacological screening and gene mapping available for licensing

Univ. of Washington offers cell line for screening compounds

Univ. of Washington offers human topo I-producing system for licensing

Intracardiac illuminator offered for licensing

Novel vaccine delivery system available for licensing

Licenses available for lung function monitor

Exclusive worldwide rights offered for peptide-cleaving endopeptidase

Potential drug screening invention available for licensing

Tularik receives patent coverage relating to drug discovery efforts

Today's news in brief

Today's news in brief

Caplyta star shines as J&J takes Intra-Cellular in $14.6B deal

Proteomics study explores how protein changes influence disease

Abbvie and Simcere enter a $1B T-cell engager deal

Drug design, drug delivery and technologies, BioWorld Science RSS

Drug design, drug delivery and technologies, BioWorld Science
RSS